General Information of the Compound
Compound ID
CP0003519
Compound Name
1-(oxan-4-yl)-8-[5-(trifluoromethyl)pyridin-3-yl]-[1,2,4]triazolo[4,3-a]quinoxaline
    Show/Hide
Formula
C20H16F3N5O
Molecular Weight
399.376
Canonical SMILES
FC(F)(F)c1cncc(c1)-c1ccc2ncc3nnc(C4CCOCC4)n3c2c1
    Show/Hide
InChI
InChI=1S/C20H16F3N5O/c21-20(22,23)15-7-14(9-24-10-15)13-1-2-16-17(8-13)28-18(11-25-16)26-27-19(28)12-3-5-29-6-4-12/h1-2,7-12H,3-6H2
    Show/Hide
InChIKey
WROQPSKLDRGJBM-UHFFFAOYSA-N
Physicochemical Property
logP
4.2523
Rotatable Bonds
2
Heavy Atom Count
29
Polar Areas
65.2
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4868065
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000154 HEK293-EBNA1-6E Homo sapiens (Human)  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS